These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19751880)

  • 21. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
    Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A
    Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of the current medical literature and assessment of current utilization patterns regarding mismatch repair protein immunohistochemistry in cutaneous Muir-Torre syndrome-associated neoplasms.
    Lee JB; Litzner BR; Vidal CI
    J Cutan Pathol; 2017 Nov; 44(11):931-937. PubMed ID: 28749576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Muir-Torre syndrome family.
    Serleth HJ; Kisken WA
    Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two patients with Muir-Torre syndrome].
    Vermeer MH; Neering H; Menko FH
    Ned Tijdschr Geneeskd; 1999 Sep; 143(39):1980. PubMed ID: 10610483
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on the pathology, genetics and somatic landscape of sebaceous tumours.
    Ferreira I; Wiedemeyer K; Demetter P; Adams DJ; Arends MJ; Brenn T
    Histopathology; 2020 Apr; 76(5):640-649. PubMed ID: 31821583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple sebaceous tumors with colon cancer--Muir-Torre syndrome].
    Vajda A; Scharrer K; Baló-Banga JM
    Orv Hetil; 2003 May; 144(20):985-9. PubMed ID: 12830729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is a cystic sebaceous neoplasm always marker for Muir-Torre syndrome?
    Arsenovic N; Ramaiya A
    Dermatol Online J; 2009 Nov; 15(11):11. PubMed ID: 19951647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muir-Torre syndrome: a case of this uncommon entity.
    Weinstein A; Nouri K; Bassiri-Tehrani S; Flores F; Jimenez G
    Int J Dermatol; 2006 Mar; 45(3):311-3. PubMed ID: 16533237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sebaceous carcinoma arising in nevus sebaceus of Jadassohn: a clinicopathological study of five cases.
    Kazakov DV; Calonje E; Zelger B; Luzar B; Belousova IE; Mukensnabl P; Michal M
    Am J Dermatopathol; 2007 Jun; 29(3):242-8. PubMed ID: 17519621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Case report: Muir-Torre syndrome diagnosed from a sebaceoma mimicking an ulcerated breast cancer].
    Demolin G; Romain M; Münschke A; Vandingenen T; Blaude MA; Van Craynest MP
    J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):767-74. PubMed ID: 26321614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome.
    Harrington CR; Egbert BM; Swetter SM
    Dermatol Surg; 2004 May; 30(5):817-9. PubMed ID: 15099333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muir-Torre syndrome.
    Johnson PJ; Heckler F
    Ann Plast Surg; 1998 Jun; 40(6):676-7. PubMed ID: 9641292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All patients with sebaceous gland neoplasms should be screened for Muir-Torre syndrome.
    Ingram JR; Griffiths AP; Roberts DL
    Clin Exp Dermatol; 2009 Mar; 34(2):264-6. PubMed ID: 19187311
    [No Abstract]   [Full Text] [Related]  

  • 34. MSH6 mutation in Muir-Torre syndrome: could this be a rare finding?
    Mangold E; Rahner N; Friedrichs N; Buettner R; Pagenstecher C; Aretz S; Friedl W; Ruzicka T; Propping P; Rütten A; Kruse R
    Br J Dermatol; 2007 Jan; 156(1):158-62. PubMed ID: 17199584
    [No Abstract]   [Full Text] [Related]  

  • 35. Ten cases of sebaceous carcinoma arising in nevus sebaceus.
    Izumi M; Tang X; Chiu CS; Nagai T; Matsubayashi J; Iwaya K; Umemura S; Tsuboi R; Mukai K
    J Dermatol; 2008 Nov; 35(11):704-11. PubMed ID: 19120764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Muir-Torre syndrome].
    Tiszlavicz L; Hódi Z; Tihanyi Z
    Orv Hetil; 1999 Jan; 140(5):251-4. PubMed ID: 10064979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of sebaceous and non-sebaceous cutaneous manifestations in patients with lynch syndrome: a systematic review.
    Aziz S; O'Sullivan H; Heelan K; Alam A; McVeigh TP
    Fam Cancer; 2023 Apr; 22(2):167-175. PubMed ID: 36418753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin.
    Ajith Kumar VK; Gold JA; Mallon E; Thomas S; Hodgson SV
    Fam Cancer; 2008; 7(2):187-9. PubMed ID: 17874208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posterior scleral choristoma in the organoid nevus syndrome (linear nevus sebaceus of Jadassohn).
    Traboulsi EI; Zin A; Massicotte SJ; Kosmorsky G; Kotagal P; Ellis FD
    Ophthalmology; 1999 Nov; 106(11):2126-30. PubMed ID: 10571348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness.
    Tischkowitz M; Gologan A; Srolovitz H; Khanna M; Foulkes WD
    Br J Cancer; 2006 Jul; 95(2):243-4. PubMed ID: 16786041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.